If you're in search for a bioanalytical partner to help advance your pre-clinical or clinical development program, look no further. Discover the bioanalytical difference at Worldwide! https://ow.ly/XziY50Sv484
Worldwide Clinical Trials’ Post
More Relevant Posts
-
Getting to grips with clinical trials: how can start-ups ensure bioanalyticalsis success? Tom Zhang, Worldwide Clinical Trials' CSO of Large Molecule Bioanalysis, details the need for bioanalytical and clinical expertise to meet assay requirements, and shares strategies for overcoming clinical trial bottlenecks >>> https://hubs.ly/Q02HM5-D0
Challenges and future opportunities in the clinical trial landscape: an interview with Tom Zhang
To view or add a comment, sign in
-
Hear from the 2024 Annual Meeting's Abstract Directors, Hannah Zierden, PhD, and Alexandros Marios Sofias, PhD, as they highlight the incredible stats we've seen with this year's abstract submissions. You can view the full Abstract topics overview here: https://ow.ly/ig0B50SmIFU #CRS2024 #deliveryscience #pharma #drugdelivery #scientist #scienceandtechnology #researchandevelopment
To view or add a comment, sign in
-
Case Study: The Impact of Cell Validation Consider a scenario where a research team is investigating a new drug’s effects on liver cells. Without validation, there is a risk that the cells used are contaminated or misidentified, leading to erroneous conclusions about the drug’s efficacy or toxicity. However, with validated hepatic cells from Vesta Bio, the research team can confidently proceed with their experiments, knowing their cells are authentic, pure, and functional. This assurance results in reliable data, successful publication, and a smoother path to potential drug development. Learn more about Vesta's cell validation services today! www.vestabiotx.com
To view or add a comment, sign in
-
#HCS_Software_and_Services Market Share Expected Huge Growth during 2022-2030 https://lnkd.in/d5v3YnnS Growing drug #discovery research owing to rising disease burden will be influencing the #growth of the market. High-content screening is a well-established approach for the #multiparametric analysis of cellular events. To get more from #biological and #clinical research, many scientists rely on high-content screening (HCS). GE GE HealthCare Thermo Fisher Scientific Hill Dickinson LLP Becton Dickenson Yokogawa Electric Corporation
To view or add a comment, sign in
-
At #Domainex we are always searching the literature to keep on top of the latest developments. In the latest edition of our "Medicinal Chemistry in Review" blog series, the focus was on a paper from Genentech which discloses the discovery of GNE7599, a VHL ligand with improved potency and cellular permeability and good oral bioavailability. https://lnkd.in/enp8JRFj We hope you enjoy reading it. #DrugDiscovery #MedChem
To view or add a comment, sign in
-
Here is a link to Domainex's recent med chem blog reviewing Genetech's recent paper on the discovery of GNE7599. I hope you find it useful.
At #Domainex we are always searching the literature to keep on top of the latest developments. In the latest edition of our "Medicinal Chemistry in Review" blog series, the focus was on a paper from Genentech which discloses the discovery of GNE7599, a VHL ligand with improved potency and cellular permeability and good oral bioavailability. https://lnkd.in/enp8JRFj We hope you enjoy reading it. #DrugDiscovery #MedChem
To view or add a comment, sign in
-
Start the year off right by checking out our web post on "Optimizing Fragment-Based Drug Discovery by NMR." This piece shares some cool insights on making drug discovery more effective using NMR techniques. 👉 https://bit.ly/3tvq3ak 👈 Plus, don't miss out on catching up with one of our recent webinars given by AbbVie's speaker. The recorded session is right there within the web post. It's a great way to kickstart the year with inspiration and knowledge! Wishing you an amazing and successful year ahead! #analyticalchemistry #FBDD #DrugDiscovery #MnovaRocks #ligandbinding #NMR #screening
To view or add a comment, sign in
-
Achieving Rapid #LC-MS Analyses Using #Avantor® #ACE® #HTP-MS #Columns Achieving fast LC analyses is essential in high sample throughput laboratories, such as clinical, drug discovery and environmental labs. Over the last two decades, #UHPLC has enabled many labs to dramatically increase sample throughput, through use of shorter columns packed with sub-2 micron particles. However, at the same time, the performance of modern mass spectrometers has continued to evolve. Improved sensitivity and ultra-fast data acquisition capabilities, provide opportunities to further reduce analytical run times, using specially designed, high throughput columns. This #webinar begins by discussing the concepts of how to develop high throughput LC-MS methods, before introducing the Avantor® ACE® HTP-MS column. The use of this column format to develop ultra-fast LC-MS analyses will be discussed, along with several key applications that demonstrate the advantages that can be realised. Finally, some of the challenges associated with rapid analysis will be discussed, including aspects of sample preparation and the impact the matrix can have on the detector. For more information, please contact us at webinar@avantorsciences.com #REGISTER NOW! https://lnkd.in/dpZ-yFhs
Achieving Rapid LC-MS Analyses Using Avantor® ACE® HTP-MS Columns
it.vwr.com
To view or add a comment, sign in
-
At what stage do you introduce biophysical tools into your drug discovery workflow? Traditionally, they’re used late in the workflow to validate hits after biochemical assays, but a new paper (https://lnkd.in/gFtT3Cqi) out of Amgen indicates that they should be used earlier in HTS. Here’s 3 reasons why: 1️⃣ Higher quality hits: Biophysically confirmed hits have higher quality-control metrics and better specificity than unconfirmed hits. 2️⃣ Increased efficiency: Introducing biophysical tools earlier streamlines the screening process, reducing time spent on false positives. 3️⃣ Improved predictive power: Getting better data earlier in the process ensures that the candidates that move forward have the best chance of making it to the clinic. Looking for a biophysical method to add to your early HTS workflow? Learn about one of the instruments mentioned in the paper — Dianthus — and how it provides in-solution and mass-independent affinity measurements: https://bit.ly/3RU6mlx
To view or add a comment, sign in
-
Did you miss the opportunity to submit your abstract due to the Easter vacation? You still have the chance, as the submission deadline has been extended to 19.04.23 🤩 . To enter the competition, simply follow these instructions: Visit our website link below 👇 Submit your abstract by April 19, 2024. NB!: The Centre for Diagnostics DTU has no interest in using your project ideas or data, and an NDA and/or a DPA can be signed where necessary. Don't miss out on this opportunity to elevate your research and potentially win valuable support for your project. If you have any questions or need further assistance, please don't hesitate to contact us. ✨ We look forward to receiving your abstract and wish you the best of luck in the competition! ✨ #drugdiscovery #proteomics #medicalsciences #biomarkers #development #healthcare #clinicalstudies #pharma #medical #biopharma #pharmacovigilance #medicalaffairs #pharmaindustry #oncology #drugdevelopment #cra #biotechnology #cro #translationalresearch #precisionmedicine #inflammatory #diseases #cytokines #panels #competition #win #pilot #study #cfd #diagnostics
CfD competition
diagnostik.dtu.dk
To view or add a comment, sign in
169,721 followers